Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 1c,Condition 2a,Condition 2b,Condition 2c,Condition 3,Condition 4 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",vasoconstriction trait,,RS:0002215,SS/HsdMcwiCrl,male,112 days,7,,CMO:0002459,phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline,[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100,phenylephrine-induced blood vessel constriction expressed as percent of force at baseline,,694.94,%,34.53,91.3578,MMO:0000342,wire myography,mesenteric artery,0.0,,,,,controlled carbohydrate content diet (53 %) (for 91 days) and controlled fat content diet (14 %) (for 91 days) and controlled protein content diet (33 %) (for 91 days) then phenylephrine (31.6 umol/l) ,84672,controlled carbohydrate content diet (53 %) (for 91 days),controlled fat content diet (14 %) (for 91 days),controlled protein content diet (33 %) (for 91 days),phenylephrine (31.6 umol/l) ,,,, 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",vasoconstriction trait,,RS:0002215,SS/HsdMcwiCrl,male,112 days,10,,CMO:0002459,phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline,[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100,phenylephrine-induced blood vessel constriction expressed as percent of force at baseline,,607.58,%,51.55,163.0154,MMO:0000342,wire myography,mesenteric artery,0.0,,,,,controlled carbohydrate content diet (53 %) (for 63 days) and controlled fat content diet (14 %) (for 63 days) and controlled protein content diet (33 %) (for 63 days) then controlled carbohydrate content diet (69 %) (for 28 days) and controlled fat content diet (12 %) (for 28 days) and controlled protein content diet (19 %) (for 28 days) then phenylephrine (31.6 umol/l) ,84673,controlled carbohydrate content diet (53 %) (for 63 days),controlled fat content diet (14 %) (for 63 days),controlled protein content diet (33 %) (for 63 days),controlled carbohydrate content diet (69 %) (for 28 days),controlled fat content diet (12 %) (for 28 days),controlled protein content diet (19 %) (for 28 days),phenylephrine (31.6 umol/l) , 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",vasoconstriction trait,,RS:0002215,SS/HsdMcwiCrl,male,112 days,6,,CMO:0002459,phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline,[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100,phenylephrine-induced blood vessel constriction expressed as percent of force at baseline,,542.39,%,49.85,122.1071,MMO:0000342,wire myography,mesenteric artery,0.0,,,,,controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days) then phenylephrine (31.6 umol/l) ,84674,controlled carbohydrate content diet (69 %) (for 91 days),controlled fat content diet (12 %) (for 91 days),controlled protein content diet (19 %) (for 91 days),phenylephrine (31.6 umol/l) ,,,, 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",vasoconstriction trait,,RS:0002215,SS/HsdMcwiCrl,male,112 days,6,,CMO:0002459,phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline,[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100,phenylephrine-induced blood vessel constriction expressed as percent of force at baseline,,641.52,%,62.37,152.7747,MMO:0000342,wire myography,mesenteric artery,0.0,,,,,controlled carbohydrate content diet (69 %) (for 63 days) and controlled fat content diet (12 %) (for 63 days) and controlled protein content diet (19 %) (for 63 days) then controlled carbohydrate content diet (53 %) (for 28 days) and controlled fat content diet (14 %) (for 28 days) and controlled protein content diet (33 %) (for 28 days) then phenylephrine (31.6 umol/l) ,84675,controlled carbohydrate content diet (69 %) (for 63 days),controlled fat content diet (12 %) (for 63 days),controlled protein content diet (19 %) (for 63 days),controlled carbohydrate content diet (53 %) (for 28 days),controlled fat content diet (14 %) (for 28 days),controlled protein content diet (33 %) (for 28 days),phenylephrine (31.6 umol/l) , 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",vasoconstriction trait,,RS:0002215,SS/HsdMcwiCrl,male,112 days,7,,CMO:0002459,phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline,[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100,phenylephrine-induced blood vessel constriction expressed as percent of force at baseline,,756.89,%,61.56,162.8725,MMO:0000342,wire myography,mesenteric artery,0.0,,,,,controlled carbohydrate content diet (53 %) (for 91 days) and controlled fat content diet (14 %) (for 91 days) and controlled protein content diet (33 %) (for 91 days) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then phenylephrine (31.6 umol/l) ,84676,controlled carbohydrate content diet (53 %) (for 91 days),controlled fat content diet (14 %) (for 91 days),controlled protein content diet (33 %) (for 91 days),NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours),,,phenylephrine (31.6 umol/l) , 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",vasoconstriction trait,,RS:0002215,SS/HsdMcwiCrl,male,112 days,9,,CMO:0002459,phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline,[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100,phenylephrine-induced blood vessel constriction expressed as percent of force at baseline,,626.89,%,61.39,184.17,MMO:0000342,wire myography,mesenteric artery,0.0,,,,,controlled carbohydrate content diet (53 %) (for 63 days) and controlled fat content diet (14 %) (for 63 days) and controlled protein content diet (33 %) (for 63 days) then controlled carbohydrate content diet (69 %) (for 28 days) and controlled fat content diet (12 %) (for 28 days) and controlled protein content diet (19 %) (for 28 days) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then phenylephrine (31.6 umol/l) ,84677,controlled carbohydrate content diet (53 %) (for 63 days),controlled fat content diet (14 %) (for 63 days),controlled protein content diet (33 %) (for 63 days),controlled carbohydrate content diet (69 %) (for 28 days),controlled fat content diet (12 %) (for 28 days),controlled protein content diet (19 %) (for 28 days),NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours),phenylephrine (31.6 umol/l) 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",vasoconstriction trait,,RS:0002215,SS/HsdMcwiCrl,male,112 days,6,,CMO:0002459,phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline,[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100,phenylephrine-induced blood vessel constriction expressed as percent of force at baseline,,564.27,%,57.82,141.6295,MMO:0000342,wire myography,mesenteric artery,0.0,,,,,controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then phenylephrine (31.6 umol/l) ,84678,controlled carbohydrate content diet (69 %) (for 91 days),controlled fat content diet (12 %) (for 91 days),controlled protein content diet (19 %) (for 91 days),NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours),,,phenylephrine (31.6 umol/l) , 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",vasoconstriction trait,,RS:0002215,SS/HsdMcwiCrl,male,112 days,5,,CMO:0002459,phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline,[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100,phenylephrine-induced blood vessel constriction expressed as percent of force at baseline,,665.33,%,79.91,178.6842,MMO:0000342,wire myography,mesenteric artery,0.0,,,,,controlled carbohydrate content diet (69 %) (for 63 days) and controlled fat content diet (12 %) (for 63 days) and controlled protein content diet (19 %) (for 63 days) then controlled carbohydrate content diet (53 %) (for 28 days) and controlled fat content diet (14 %) (for 28 days) and controlled protein content diet (33 %) (for 28 days) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then phenylephrine (31.6 umol/l) ,84679,controlled carbohydrate content diet (69 %) (for 63 days),controlled fat content diet (12 %) (for 63 days),controlled protein content diet (19 %) (for 63 days),controlled carbohydrate content diet (53 %) (for 28 days),controlled fat content diet (14 %) (for 28 days),controlled protein content diet (33 %) (for 28 days),NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours),phenylephrine (31.6 umol/l)